Real-World Evidence (RWE) jobs for Health Economists.
Looking for a career in health economics and real-world evidence (RWE)? Check out the latest job openings in the pharmaceutical industry. There are many new opportunities available for RWE analysts, real-world evidence scientists, RWE managers, and real-world evidence market access managers in both pharmaceutical and life science consulting companies.
Maple Grove / Arden Hills, MN, US. The Senior HEMA Manager will lead the development and implementation of health policy and reimbursement initiatives in support of Boston Scientific’s Interventional Cardiology Business Unit. This role involves cross-functional and global collaboration to ensure appropriate reimbursement for existing and emerging technologies. The individual will be responsible for providing strategic input to product development teams. … Read more
Home-based, US. Reporting to the HEOR Therapeutic Area (TA) Head, the HEOR Director is accountable for developing the comprehensive HEOR plan and executing on the HEOR Book of Work, strategically aligned with the Access Strategy Lead (ASL), for a portfolio of assets across the life cycle management The HEOR Book of Work comprises generating global-impact payer-relevant evidence, patient reported outcomes … Read more
Cambridge, MA / Bothell, WA, US. You will generate HEOR real-world evidence to drive patient access to diverse innovations from Philips businesses being part of the global Health Economics team within the Health Economics, Market Access, and Reimbursement Department. In this role you will be responsible for: You’re the right fit if: Other locations: Colorado Springs, CO; Nashville, TN; Plymouth, … Read more
Hyderabad, India. The overall purpose and main responsibilities are listed below: Create HEVA communications deliverables (including manuscripts, posters, abstracts, slide decks) aligned with HEVA strategy and global HEVA communication plan across relevant business units and product teams. Manage core HEVA communication processes, templates, and products across the portfolio in accordance with the scientific and value messages aligned with Core Value … Read more
Shanghai, China. Major Responsibilities: Cooperate with PVU to determine the clinical value, patient value and product value proposition of UCB products in the Chinese market based on medical evidence, and complete various tasks at the execution level. Cooperate with PVU to design and execute pharmacoeconomic studies, patient outcome studies, disease burden studies, RWE studies, etc. of UCB products to ensure timely and efficient completion of the … Read more
Singapore. Provides high quality, timely development and on-time input to client solutions for the pharmaceutical and related industries. Assignments range in complexity from basic analysis and problem solving to assisting in the development of more complex solutions to leading small teams. Principal Accountabilities: Minimum Education, Experience Required: IQVIA™ is The Human Data Science Company™, focused on using data and science … Read more
Mississauga, Canada. The Senior Director, Market Access will be responsible for leading, developing, championing and overall execution of reimbursement, negotiation and pricing strategies for Alexion Canada and managing the relevant relationships with public payers, government officials, hospital pharmacies, private payers, and other external partners across the Alexion portfolio. Reporting to the General Manager of Alexion Canada, the Senior Director, Market … Read more
Mexico City, Mexico. We are looking for a Pharmacoeconomics RWE Manager who has the ability to work multifunctionally, in a team, good communication skills, assertive communication, leadership, work under pressure, enabling effective collaboration with diverse stakeholders to join us in our team, based in CDMX. About the role: Leads, develops and implements pharmacoeconomic analyzes and strategies for the entire UCB portfolio, … Read more
Seoul, South Korea. Works directly with clients to provide value added input, to develop business opportunities that will lead to additional starbursts and to deliver projects built around strategic issues. Has responsibility for ensuring delivery of high levels of client satisfaction. Typically works within a specific CoE area but may have responsibility across multiple expertise areas and/or clients. Meets or … Read more
Seoul, South Korea. Are you passionate about driving strategic initiatives and programs in the field of Real World Evidence (RWE)? Do you have experience in managing teams and engaging with stakeholders? If so, we have an exciting opportunity for you to join our Clinical, Medical, Regulatory Affairs (CMR) department as a Real World Evidence Manager. Read on to learn more … Read more
Seoul, South Korea. This is a 1-year contract-based position that could be extended based on the new joiner’s performance assessment. Are you passionate about driving strategic initiatives and programs in the field of Real World Evidence (RWE)? If so, we have an exciting opportunity for you to join our Clinical, Medical, Regulatory Affairs (CMR) department as a Real World Evidence … Read more
Singapore. Our HEOR team includes highly qualified multi-disciplinary experts. They are based throughout Asia with a focused footprint in the SEA. The HEOR practice is part of the IQVIA Real-World Insights business unit that connects healthcare stakeholders through knowledge, skills, practical experience, creativity and data to demonstrate the value of medicines, enhance quality of care and drive improvement of patient … Read more
Toronto, Canada. Johnson & Johnson Innovative Medicine (JJIM) is recruiting for an Associate Director, Real World Evidence Methods, located in Toronto, Canada. The Associate Director, Real World Evidence Methods is an RWE leader role within the Evidence Generation Centre at Janssen Canada. This dynamic leader will directly support the Director, Evidence Generation Centre in shaping Janssen’s Evidence Generation strategy. This … Read more
México City, Mexico. Your Tasks & Responsibilities: 1. Responsible and accountable for the RWE plans across all categories, brands, and products on a global, and local level by developing innovative and pioneering RWE strategies, approaches, and studies. In this role the incumbent leads creative approaches to problem solving and development of new RWE deliverables and is responsible as well as … Read more
Real-World Evidence in Health Economics
Real-World Evidence in Health Economics
Real-world evidence (RWE) has become an increasingly important aspect of health economics research in recent years. It provides a comprehensive and in-depth understanding of how different health interventions work in real-world settings.
What is Real-World Evidence?
Real-world evidence (RWE) is defined as data collected from sources other than traditional randomized controlled trials (RCTs). These data come from a variety of sources, including electronic health records (EHRs), claims databases, registries, patient-reported outcomes (PROs), and surveys.
RWE allows researchers to evaluate the effectiveness, safety, and cost-effectiveness of health interventions in real-world settings. This is important because RCTs often have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations.
Importance of Real-World Evidence in Health Economics
RWE is becoming increasingly important in health economics because it provides a more complete picture of the effectiveness and safety of health interventions. By using RWE, researchers can evaluate how interventions work in a variety of settings and patient populations, which can help inform clinical practice and policy decisions.
RWE can also be used to conduct cost-effectiveness analyses, which help policymakers determine the value of health interventions. Cost-effectiveness analyses compare the costs and benefits of different health interventions, taking into account the costs of the intervention as well as the costs of any adverse events or complications that may occur.
Differences between RWE and Randomized Controlled Trials (RCTs)
RCTs are considered the gold standard for evaluating the effectiveness and safety of health interventions. However, there are several key differences between RWE and RCTs.
RCTs are conducted under controlled conditions and have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations. RWE, on the other hand, is collected from a variety of sources and reflects the real-world experiences of patients.
RCTs also tend to be shorter in duration than RWE studies, which means that they may not capture the long-term effects of health interventions. RWE studies, on the other hand, can provide information on the long-term effectiveness and safety of interventions.
Methods of Collecting RWE
There are several methods of collecting RWE, including:
Electronic Health Records (EHRs) EHRs are digital records of patient health information that are maintained by healthcare providers. EHRs can provide a wealth of information on patient demographics, diagnoses, treatments, and outcomes.
Claims Databases Claims databases contain information on healthcare services and medications that are billed to insurance providers. Claims data can provide information on healthcare utilization, costs, and outcomes.
Registries Registries are databases that collect information on specific diseases or health conditions. They can provide valuable information on disease prevalence, treatment patterns, and outcomes.
Patient-Reported Outcomes (PROs) PROs are questionnaires or surveys completed by patients that assess their health status, symptoms, and quality of life. PROs can provide information on patient preferences and experiences with different interventions.
Surveys Surveys can be used to collect information on patient demographics, health behaviors, and healthcare utilization. They can also be used to assess patient preferences and satisfaction with different interventions.
Advantages of Real-World Evidence
There are several advantages of using RWE in health economics research, including:
RWE reflects real-world experiences and can provide a more comprehensive understanding of the effectiveness and safety of interventions.
RWE can be used to evaluate interventions in a variety of settings and patient populations.
RWE can provide information on the long-term effectiveness and safety of interventions.
RWE can be used to conduct cost-effectiveness analyses, which can inform clinical practice and policy decisions.
Challenges and Limitations of Real-World Evidence
There are several challenges and limitations to using RWE in health economics research, including:
RWE can be subject to bias and confounding, which can affect the validity of the results.
RWE can be difficult to collect and analyze, particularly when using multiple data sources.
RWE may not be as well-suited for evaluating rare diseases or interventions.
Applications of Real-World Evidence
RWE has several applications in health economics research, including:
Health Technology Assessment Health technology assessment (HTA) is a process that evaluates the clinical effectiveness, safety, and cost-effectiveness of new health technologies. RWE can be used in HTA to provide information on the real-world effectiveness and safety of interventions.
Comparative Effectiveness Research Comparative effectiveness research (CER) compares the effectiveness of different interventions for the same health condition. RWE can be used in CER to compare the effectiveness of interventions in different patient populations and settings.
Post-Marketing Surveillance Post-marketing surveillance is the process of monitoring the safety and effectiveness of new drugs and medical devices after they have been approved for use. RWE can be used in post-marketing surveillance to monitor the long-term safety and effectiveness of interventions.
Future of Real-World Evidence in Health Economics
RWE is likely to become increasingly important in health economics research in the future. Advances in technology and data analytics are making it easier to collect and analyze RWE, and policymakers are recognizing the importance of using RWE to inform clinical practice and policy decisions.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Sempre attivo
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
